Next generation vaccines to protect people and our animals from neuroinvasive herpesvirus infections

Our proprietary technology selectively removes neuroinvasive potential by eliminating a viral component that is responsible for the transmission of these viruses into the nervous system. The component, R2, is named for region 2 of the pUL37 tegument protein. The neutered vaccines keep the nervous system pristine and free of virus while fortifying the immune system with remarkable efficacy. No adjuvants or repeat vaccinations are necessary.